Health
FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease – Medical Xpress
In 2014, two years after her Nobel Prize-winning invention of CRISPR-Cas9 genome editing, Jennifer Doudna thought the technology was mature enough to tackle a cure…
In 2014, two years after her Nobel Prize-winning invention of CRISPR-Cas9 genome editing, Jennifer Doudna thought the technology was mature enough to tackle a cure for a devastating hereditary disorder, sickle cell disease, that afflicts millions of people around the world, most of them of African descent. Some 100,000 Black people in the U.S. are afflicted with the disease.
Mobilizing colleagues in the then-new Innovative Genome Institute (IGI)a joint research collaboration between the University…
-
Noosa News21 hours agoOne-punch killer jailed for hospital and prison assault
-
Noosa News21 hours agoThieves crash car into Gladstone Central Plaza in Central Queensland to rob jewellery shop after hours
-
Business20 hours ago5 ASX growth shares to buy and hold
-
Noosa News22 hours agoPolice say recent arrests highlight risk posed to children by online predators